For CoreWeave, $150 is more than a round psychological number. It sits just under the stock's all-time closing high of $153.20, meaning a move to $150 would essentially represent a full recovery of the losses incurred since late 2025. It also aligns closely with the analyst consensus, which averages near $144, making it a realistic benchmark rather than an arbitrary milestone. Reclaiming this level would signal that the market once again believes CoreWeave can convert its breakneck growth into durable profitability.
CoreWeave is a "neocloud" — a specialized cloud provider built specifically for AI and high-performance computing, rather than a general-purpose platform. Founded in 2017 and based in Livingston, New Jersey, the company went public in March 2025. Its platform combines Nvidia GPUs with proprietary software to help AI labs and enterprises run demanding workloads at scale. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The growth story is striking. In the second quarter of 2026, CoreWeave reported revenue of $2.58 billion, up 112% year over year, and raised its full-year revenue guidance to a range of $12.4 billion to $13.2 billion. Its revenue backlog swelled to roughly $104 billion, and the company has highlighted demand that continues to exceed available supply.
Pricing power is another tailwind. After Nvidia (NVDA) reportedly raised prices on its latest GPUs by more than 15%, CoreWeave lifted prices across its product line by 25% in July. Analysts at Truist argue this pricing leverage could lift contribution margins on longer-duration contracts from roughly 24% toward 33%, directly supporting the path to profitability.
Capacity expansion also underpins the bullish case. CoreWeave reached 1.5 gigawatts of active power in the second quarter and has guided toward roughly 1.85 gigawatts by the end of 2026, providing the infrastructure needed to service its growing order book. From what I see, these elements form a solid base if execution stays on track.
The balance sheet is the clearest risk. CoreWeave carries roughly $51.6 billion in total debt against about $6.4 billion in cash, and it remains unprofitable on a net basis — posting an adjusted loss of $1.03 per share in the latest quarter. The company raised its capital expenditures (capex) target to $35 billion to $39 billion for 2026, underscoring how much cash the buildout consumes.
Customer concentration is another concern. Microsoft has historically accounted for a large majority of revenue — around 71% in the second quarter of 2025 — though management has emphasized efforts to diversify its client base. Any slowdown in AI-related capital spending from hyperscale customers, or a deterioration in financing conditions, could pressure both growth and the stock's valuation.
Wall Street remains broadly constructive but not unanimous. The consensus rating sits at a Moderate Buy, with an average price target near $144 and individual targets spanning from roughly $74 to $317. Truist recently raised its target to $165 from $155, while Morningstar lifted its fair-value estimate to $115; Bernstein, by contrast, holds an Underperform stance with a $74 target.
From a technical perspective, the $83–$87 area has served as recent support following a sharp pullback, while $153.20 represents the major overhead resistance zone. A sustained move through $150 would require clearing that prior high with conviction, backed by improving fundamentals rather than sentiment alone. I’m watching this closely as margin trends develop.
For traders tracking momentum around levels like $150, Tickeron's AI Daily Buy/Sell Signals have become a useful part of my routine. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. It helps me spot changing conditions in names like CoreWeave without getting lost in the noise, and I’ve found it particularly handy for monitoring support and resistance zones in real time.
A return to $150 is ambitious but not unrealistic. CoreWeave's rapid revenue growth, expanding backlog, pricing power, and capacity buildout provide a credible foundation, and the analyst consensus near $144 suggests the market already prices in meaningful upside. However, the path is far from assured: the company's heavy debt load, persistent losses, and reliance on a small number of large customers leave little margin for error. Investors should watch margin trends, backlog conversion, customer diversification, and whether the stock can hold above its recent support zone before considering a move toward the prior high.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 10-day RSI Oscillator for CRWV moved out of overbought territory on August 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRWV as a result. In of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CRWV turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .
CRWV moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRWV broke above its upper Bollinger Band on August 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRWV entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for CRWV crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.470) is normal, around the industry mean (22.357). P/E Ratio (0.000) is within average values for comparable stocks, (70.413). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.162). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (5.921) is also within normal values, averaging (109.528).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows